Shortly before the end of 2023, two more digital health applications have received their approval in the DiGA directory: Untire® for fatigue caused by breast cancer from the Dutch manufacturer Tired of Cancer B.V. and actensio for high blood pressure from the German manufacturer mementor DE GmbH. mementor already has the permanently listed DiGA somnio in its portfolio for the treatment of insomnia and sleep disorders.
A total of 52 active DiGAs are available in the DiGA directory at the start of the year. The BfArM is currently processing 20 applications for DiGA approval.